Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Market Growth 2026-2032

October 2026 | 144 pages | ID: G044AD23DE5AEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits market size is predicted to grow from US$ 15.85 million in 2025 to US$ 32.01 million in 2032; it is expected to grow at a CAGR of 11.0% from 2026 to 2032.

HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits are in vitro diagnostic products designed for the simultaneous qualitative screening of four major blood-borne or sexually transmitted infections through a single commercial testing system. The products primarily use immunochromatographic lateral-flow technology and detect HIV-1/2 antibodies, hepatitis B surface antigen HBsAg, antibodies to hepatitis C virus, and antibodies to Treponema pallidum in whole blood, serum, or plasma specimens. Commercial products are generally supplied as visually read rapid-test cassettes or multi-panel devices, enabling trained health-care personnel to obtain multiple screening results without large automated laboratory instruments. The study focuses on professional-use quadruple rapid tests used in integrated infectious-disease screening, primary and decentralized health-care settings, selected low-throughput blood-screening environments, medical examination and perioperative screening, and other point-of-care programs where simultaneous testing can reduce specimen handling and testing steps. The product definition is consistent with the technical scope established for immunochromatographic HIV, HBV, HCV and syphilis four-infectious-disease combined detection kits under the relevant Chinese industry standard.

Key Findings

China represents the principal manufacturing cluster for commercial quadruple rapid test kits

The validated competitive set comprises 17 core manufacturing entities or groups

Market Trends

HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits are developing within the broader transition from single-pathogen rapid diagnostics toward integrated and multiplex infectious-disease screening. Product development is moving toward one-specimen, multi-analyte workflows, simpler visual interpretation, reduced testing steps and improved suitability for decentralized health-care environments. In July 2025, the World Health Organization prequalified the first rapid antenatal panel simultaneously covering HIV, hepatitis B and syphilis and subsequently initiated the development of global guidance for multiplex testing across HIV, viral hepatitis and sexually transmitted infections. These developments do not constitute specific endorsement of the four-analyte HIV/HBV/HCV/syphilis format, but they strengthen the long-term policy and clinical rationale for integrated testing. China has also moved toward greater product standardization, with a 2025 standard specifically defining technical requirements for immunochromatographic HIV, HBV, HCV and syphilis four-infectious-disease combined detection kits.

Market Dynamics

Drivers

Demand is supported by the need to consolidate multiple infectious-disease screening procedures into fewer testing steps, particularly in primary care, decentralized testing programs and resource-constrained health systems. HIV, hepatitis B, hepatitis C and syphilis frequently coexist within blood-safety, public-health and risk-based screening frameworks, creating a clear operational rationale for multiplex rapid diagnostics. WHO recommends screening all blood donations for HIV, hepatitis B, hepatitis C and syphilis, providing a large underlying testing pool, while broader adoption of integrated service delivery is increasing interest in multi-pathogen rapid-test formats.

Restraints

The market remains substantially smaller than the combined markets for the four individual rapid tests because many screening programs do not require all four markers at the same encounter. Large hospitals, centralized laboratories and high-throughput blood centers commonly rely on automated immunoassay, chemiluminescence or nucleic-acid testing systems, limiting the penetration of rapid quadruple products in advanced laboratory environments. In addition, widely deployed HIV/syphilis dual tests and emerging three-analyte antenatal panels already address important integrated-testing scenarios and may reduce the incremental need for a four-analyte format in selected programs.

Opportunities

The principal opportunity lies in countries and health systems seeking to expand integrated screening without corresponding investment in complex laboratory infrastructure. Expansion of hepatitis B and hepatitis C case finding, combined HIV and STI services, decentralized screening programs and low-throughput testing sites can increase the addressable population for HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits. Further opportunities may arise from improved product registration, clearer multiplex-testing guidance, standardized technical requirements and broader procurement acceptance in emerging markets.

Challenges

Commercialization remains dependent on country-specific regulatory approval, diagnostic algorithms and procurement policies. Multiplex products must demonstrate acceptable analytical performance for four separate markers within a single device while maintaining competitive cost per patient, stable manufacturing quality and straightforward interpretation. The presence of numerous OEM and private-label relationships also complicates competitive analysis and can intensify price competition, while the absence of broad international prequalification specifically for the strict four-analyte format remains a barrier to wider institutional procurement.

Industry Chain Analysis

The upstream segment consists primarily of recombinant antigens, monoclonal and polyclonal antibodies, colloidal-gold or other labeling materials, nitrocellulose membranes, sample pads, absorbent materials, plastic cassettes, buffers, desiccants and packaging materials. Diagnostic performance depends heavily on the specificity and stability of biological raw materials, membrane consistency, conjugation chemistry and strip-manufacturing control. Larger manufacturers increasingly integrate antigen and antibody development, reagent formulation, strip coating, cutting, cassette assembly, packaging and quality-control processes to improve consistency and manage manufacturing costs.

The midstream segment comprises IVD manufacturers responsible for assay development, process validation, regulated production, registration and commercial supply of the finished quadruple test. Current manufacturing capacity substantially exceeds demand for this individual SKU because most producers operate flexible rapid-test platforms serving many infectious-disease products. Downstream value is created through distributors, public-health procurement systems, hospitals, clinics, screening programs, medical examination centers and selected blood-screening facilities. Profitability is therefore influenced less by absolute production capacity than by regulatory access, procurement qualification, product reliability, channel coverage and manufacturing scale.

Segment Insights

Current commercial supply is concentrated in immunochromatographic cassette and panel formats designed for whole blood, serum or plasma. Product differentiation is primarily based on cassette architecture, number and arrangement of detection windows, sample handling, reading time, packaging configuration and whether interpretation is entirely visual or may be supported by a reader. The mainstream commercial proposition is not higher analytical complexity but the ability to consolidate four separate screening targets into a single workflow. Products that minimize sample volume, reduce operational steps and maintain clearly separated result interpretation are better positioned for decentralized professional testing.

Within the existing product structure, professional-use rapid testing remains the dominant commercial model. The strongest product opportunity is therefore expected to come from designs optimized for routine clinical and public-health workflows rather than consumer self-testing. Competitive differentiation is increasingly linked to validated performance, manufacturing consistency, registration coverage, shelf life and the ability to supply large institutional orders at a low per-test cost.

Downstream Market Opportunities

The most relevant downstream opportunities are integrated infectious-disease screening programs in primary and community health services, risk-group screening, medical examination and perioperative testing, and selected low-throughput blood-safety environments. WHO reports approximately 120.4 million blood donations globally and recommends mandatory screening of donated blood for HIV, hepatitis B, hepatitis C and syphilis; however, the opportunity for rapid quadruple tests is concentrated in decentralized and lower-throughput settings rather than centralized high-volume laboratories. Additional potential exists where health systems seek to combine HIV, viral hepatitis and STI testing into a single patient encounter, particularly in low- and middle-income markets.

Regional Insights

China is the most important manufacturing base for HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits, supported by a dense rapid-diagnostic manufacturing ecosystem, large-scale immunochromatographic production capacity and extensive OEM and export capabilities. India represents another strategically important manufacturing and demand market, while Southeast Asia, Africa, Latin America and parts of the Middle East provide meaningful opportunities for decentralized infectious-disease screening and imported rapid diagnostics. These markets generally offer stronger commercial alignment with low-cost multiplex testing than high-income markets dominated by centralized laboratory infrastructure.

North America, Europe, Japan and South Korea have advanced IVD markets and substantial infectious-disease testing expenditure, but the strict four-analyte rapid-test format has more limited penetration because established laboratory pathways, regulatory requirements and alternative dual or single-analyte products remain strong. Regional growth therefore depends less on overall diagnostic expenditure and more on whether local screening algorithms recognize a clinical and economic role for integrated rapid testing.

Competitive Landscape Analysis

The competitive landscape is characterized by a combination of large Chinese POCT manufacturers, specialized rapid-diagnostic companies in the United States and Europe, and an important Indian manufacturing presence. The validated core competitive universe contains 17 manufacturing entities or consolidated groups. Large-scale participants include Guangzhou Wondfo Biotech, ACON Biotech Hangzhou, Hangzhou AllTest Biotech, Zhejiang Orient Gene Biotech, InTec PRODUCTS and Tulip Diagnostics, while companies such as Hangzhou Biotest, Assure Tech, CTK Biotech, Hangzhou Realy Tech, Hangzhou Testsea and AccuBioTech form an important specialized middle tier. Group relationships materially affect competitive analysis: Hangzhou Tongzhou, CITEST and Aceso are consolidated within the Hangzhou AllTest system; Healgen is consolidated within Zhejiang Orient Gene; Fortress Diagnostics and Biorex Diagnostics are treated under Fortress Group Holdings; and CTK Biotech operates within SSI Diagnostica Group. Competition is driven primarily by assay reliability, manufacturing scale, regulatory registrations, export coverage, OEM capability and price, rather than by proprietary instrumentation. The fragmented supplier base and broad availability of lateral-flow manufacturing capacity continue to place downward pressure on average selling prices.

Report Scope

LP Information, Inc. (LPI) ' newest research report, the “HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Industry Forecast” looks at past sales and reviews total world HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits sales in 2025, providing a comprehensive analysis by region and market sector of projected HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits sales for 2026 through 2032. With HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits industry.

This Insight Report provides a comprehensive analysis of the global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits.

This report presents a comprehensive overview, market shares, and growth opportunities of HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

Segmentation by Type:

  • Single-Device Integrated Cassette
  • Dual-Cassette Panel Holder
  • Other

Segmentation by Specimen Compatibility:

  • Whole-Blood-Compatible Products
  • Serum-Plasma Products
  • Other

Segmentation by Application:

  • Preoperative Screening
  • Antenatal Screening
  • STI Screening
  • Transfusion-Transmitted Infection Screening
  • Other

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • ACON Biotech Hangzhou Co., Ltd.
  • Hangzhou AllTest Biotech Co., Ltd.
  • Zhejiang Orient Gene Biotech Co., Ltd.
  • InTec PRODUCTS, INC.
  • Tulip Diagnostics Pvt Ltd
  • Hangzhou Biotest Biotech Co., Ltd.
  • Assure Tech Hangzhou Co., Ltd.
  • CTK Biotech, Inc.
  • Hangzhou Realy Tech Co., Ltd.
  • Hangzhou Testsea Biotechnology Co., Ltd.
  • AccuBioTech Co., Ltd.
  • Fortress Group Holdings Limited
  • Zhejiang Wantaifu Biotechnology Co., Ltd.
  • Ningbo Best-Test Biotechnology Co., Ltd.
  • Gaobeidian PRISES Biotechnology Co., Ltd.
  • Nantong Diagnos Biotechnology Co., Ltd.

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits market?
  • What factors are driving HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits market opportunities vary by end market size?
  • How does HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits by Country/Region, 2021, 2025 & 2032
2.2 HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Segment by Type
  2.2.1 Single-Device Integrated Cassette
  2.2.2 Dual-Cassette Panel Holder
  2.2.3 Other
  2.2.4 HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Type
    2.2.4.1 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Type (2021-2026)
    2.2.4.2 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sale Price by Type (2021-2026)
2.3 HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Segment by Specimen Compatibility
  2.3.1 Whole-Blood-Compatible Products
  2.3.2 Serum-Plasma Products
  2.3.3 Other
  2.3.4 HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Specimen Compatibility
    2.3.4.1 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Specimen Compatibility (2021-2026)
    2.3.4.2 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue and Market Share by Specimen Compatibility (2021-2026)
    2.3.4.3 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sale Price by Specimen Compatibility (2021-2026)
2.4 HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Segment by Application
  2.4.1 Preoperative Screening
  2.4.2 Antenatal Screening
  2.4.3 STI Screening
  2.4.4 Transfusion-Transmitted Infection Screening
  2.4.5 Other
  2.4.6 HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Application
    2.4.6.1 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sale Market Share by Application (2021-2026)
    2.4.6.2 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue and Market Share by Application (2021-2026)
    2.4.6.3 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Breakdown Data by Company
  3.1.1 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Annual Sales by Company (2021-2026)
  3.1.2 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Company (2021-2026)
3.2 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Annual Revenue by Company (2021-2026)
  3.2.1 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Company (2021-2026)
  3.2.2 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Company (2021-2026)
3.3 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sale Price by Company
3.4 Key Manufacturers HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Location Distribution
  3.4.2 Players HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR HIV/HBV/HCV/SYPHILIS QUADRUPLE RAPID TEST KITS BY GEOGRAPHIC REGION

4.1 World Historic HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Market Size by Geographic Region (2021-2026)
  4.1.1 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Market Size by Country/Region (2021-2026)
  4.2.1 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Annual Sales by Country/Region (2021-2026)
  4.2.2 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Annual Revenue by Country/Region (2021-2026)
4.3 Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Growth
4.4 APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Growth
4.5 Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Growth
4.6 Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Growth

5 AMERICAS

5.1 Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Country
  5.1.1 Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Country (2021-2026)
  5.1.2 Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Country (2021-2026)
5.2 Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Type (2021-2026)
5.3 Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Region
  6.1.1 APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Region (2021-2026)
  6.1.2 APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Region (2021-2026)
6.2 APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Type (2021-2026)
6.3 APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits by Country
  7.1.1 Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Country (2021-2026)
  7.1.2 Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Country (2021-2026)
7.2 Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Type (2021-2026)
7.3 Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits by Country
  8.1.1 Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Country (2021-2026)
  8.1.2 Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Country (2021-2026)
8.2 Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Type (2021-2026)
8.3 Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits
10.3 Manufacturing Process Analysis of HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits
10.4 Industry Chain Structure of HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Distributors
11.3 HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Customer

12 WORLD FORECAST REVIEW FOR HIV/HBV/HCV/SYPHILIS QUADRUPLE RAPID TEST KITS BY GEOGRAPHIC REGION

12.1 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Market Size Forecast by Region
  12.1.1 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Forecast by Region (2027-2032)
  12.1.2 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Forecast by Type (2027-2032)
12.7 Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Guangzhou Wondfo Biotech Co., Ltd.
  13.1.1 Guangzhou Wondfo Biotech Co., Ltd. Company Information
  13.1.2 Guangzhou Wondfo Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.1.3 Guangzhou Wondfo Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Guangzhou Wondfo Biotech Co., Ltd. Main Business Overview
  13.1.5 Guangzhou Wondfo Biotech Co., Ltd. Latest Developments
13.2 ACON Biotech Hangzhou Co., Ltd.
  13.2.1 ACON Biotech Hangzhou Co., Ltd. Company Information
  13.2.2 ACON Biotech Hangzhou Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.2.3 ACON Biotech Hangzhou Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 ACON Biotech Hangzhou Co., Ltd. Main Business Overview
  13.2.5 ACON Biotech Hangzhou Co., Ltd. Latest Developments
13.3 Hangzhou AllTest Biotech Co., Ltd.
  13.3.1 Hangzhou AllTest Biotech Co., Ltd. Company Information
  13.3.2 Hangzhou AllTest Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.3.3 Hangzhou AllTest Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Hangzhou AllTest Biotech Co., Ltd. Main Business Overview
  13.3.5 Hangzhou AllTest Biotech Co., Ltd. Latest Developments
13.4 Zhejiang Orient Gene Biotech Co., Ltd.
  13.4.1 Zhejiang Orient Gene Biotech Co., Ltd. Company Information
  13.4.2 Zhejiang Orient Gene Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.4.3 Zhejiang Orient Gene Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Zhejiang Orient Gene Biotech Co., Ltd. Main Business Overview
  13.4.5 Zhejiang Orient Gene Biotech Co., Ltd. Latest Developments
13.5 InTec PRODUCTS, INC.
  13.5.1 InTec PRODUCTS, INC. Company Information
  13.5.2 InTec PRODUCTS, INC. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.5.3 InTec PRODUCTS, INC. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 InTec PRODUCTS, INC. Main Business Overview
  13.5.5 InTec PRODUCTS, INC. Latest Developments
13.6 Tulip Diagnostics Pvt Ltd
  13.6.1 Tulip Diagnostics Pvt Ltd Company Information
  13.6.2 Tulip Diagnostics Pvt Ltd HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.6.3 Tulip Diagnostics Pvt Ltd HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Tulip Diagnostics Pvt Ltd Main Business Overview
  13.6.5 Tulip Diagnostics Pvt Ltd Latest Developments
13.7 Hangzhou Biotest Biotech Co., Ltd.
  13.7.1 Hangzhou Biotest Biotech Co., Ltd. Company Information
  13.7.2 Hangzhou Biotest Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.7.3 Hangzhou Biotest Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Hangzhou Biotest Biotech Co., Ltd. Main Business Overview
  13.7.5 Hangzhou Biotest Biotech Co., Ltd. Latest Developments
13.8 Assure Tech Hangzhou Co., Ltd.
  13.8.1 Assure Tech Hangzhou Co., Ltd. Company Information
  13.8.2 Assure Tech Hangzhou Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.8.3 Assure Tech Hangzhou Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Assure Tech Hangzhou Co., Ltd. Main Business Overview
  13.8.5 Assure Tech Hangzhou Co., Ltd. Latest Developments
13.9 CTK Biotech, Inc.
  13.9.1 CTK Biotech, Inc. Company Information
  13.9.2 CTK Biotech, Inc. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.9.3 CTK Biotech, Inc. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 CTK Biotech, Inc. Main Business Overview
  13.9.5 CTK Biotech, Inc. Latest Developments
13.10 Hangzhou Realy Tech Co., Ltd.
  13.10.1 Hangzhou Realy Tech Co., Ltd. Company Information
  13.10.2 Hangzhou Realy Tech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.10.3 Hangzhou Realy Tech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Hangzhou Realy Tech Co., Ltd. Main Business Overview
  13.10.5 Hangzhou Realy Tech Co., Ltd. Latest Developments
13.11 Hangzhou Testsea Biotechnology Co., Ltd.
  13.11.1 Hangzhou Testsea Biotechnology Co., Ltd. Company Information
  13.11.2 Hangzhou Testsea Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.11.3 Hangzhou Testsea Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Hangzhou Testsea Biotechnology Co., Ltd. Main Business Overview
  13.11.5 Hangzhou Testsea Biotechnology Co., Ltd. Latest Developments
13.12 AccuBioTech Co., Ltd.
  13.12.1 AccuBioTech Co., Ltd. Company Information
  13.12.2 AccuBioTech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.12.3 AccuBioTech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 AccuBioTech Co., Ltd. Main Business Overview
  13.12.5 AccuBioTech Co., Ltd. Latest Developments
13.13 Fortress Group Holdings Limited
  13.13.1 Fortress Group Holdings Limited Company Information
  13.13.2 Fortress Group Holdings Limited HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.13.3 Fortress Group Holdings Limited HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Fortress Group Holdings Limited Main Business Overview
  13.13.5 Fortress Group Holdings Limited Latest Developments
13.14 Zhejiang Wantaifu Biotechnology Co., Ltd.
  13.14.1 Zhejiang Wantaifu Biotechnology Co., Ltd. Company Information
  13.14.2 Zhejiang Wantaifu Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.14.3 Zhejiang Wantaifu Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Zhejiang Wantaifu Biotechnology Co., Ltd. Main Business Overview
  13.14.5 Zhejiang Wantaifu Biotechnology Co., Ltd. Latest Developments
13.15 Ningbo Best-Test Biotechnology Co., Ltd.
  13.15.1 Ningbo Best-Test Biotechnology Co., Ltd. Company Information
  13.15.2 Ningbo Best-Test Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.15.3 Ningbo Best-Test Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 Ningbo Best-Test Biotechnology Co., Ltd. Main Business Overview
  13.15.5 Ningbo Best-Test Biotechnology Co., Ltd. Latest Developments
13.16 Gaobeidian PRISES Biotechnology Co., Ltd.
  13.16.1 Gaobeidian PRISES Biotechnology Co., Ltd. Company Information
  13.16.2 Gaobeidian PRISES Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.16.3 Gaobeidian PRISES Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.16.4 Gaobeidian PRISES Biotechnology Co., Ltd. Main Business Overview
  13.16.5 Gaobeidian PRISES Biotechnology Co., Ltd. Latest Developments
13.17 Nantong Diagnos Biotechnology Co., Ltd.
  13.17.1 Nantong Diagnos Biotechnology Co., Ltd. Company Information
  13.17.2 Nantong Diagnos Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
  13.17.3 Nantong Diagnos Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  13.17.4 Nantong Diagnos Biotechnology Co., Ltd. Main Business Overview
  13.17.5 Nantong Diagnos Biotechnology Co., Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single-Device Integrated Cassette
Table 4. Major Players of Dual-Cassette Panel Holder
Table 5. Major Players of Other
Table 6. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Type (2021-2026) & (Units)
Table 7. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Type (2021-2026)
Table 8. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Type (2021-2026) & ($ million)
Table 9. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Type (2021-2026)
Table 10. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Whole-Blood-Compatible Products
Table 12. Major Players of Serum-Plasma Products
Table 13. Major Players of Other
Table 14. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Specimen Compatibility (2021-2026) & (Units)
Table 15. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Specimen Compatibility (2021-2026)
Table 16. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Specimen Compatibility (2021-2026) & ($ million)
Table 17. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Specimen Compatibility (2021-2026)
Table 18. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sale Price by Specimen Compatibility (2021-2026) & (US$/Unit)
Table 19. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sale by Application (2021-2026) & (Units)
Table 20. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sale Market Share by Application (2021-2026)
Table 21. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Application (2021-2026) & ($ million)
Table 22. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Application (2021-2026)
Table 23. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sale Price by Application (2021-2026) & (US$/Unit)
Table 24. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Company (2021-2026) & (Units)
Table 25. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Company (2021-2026)
Table 26. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Company (2021-2026) & ($ millions)
Table 27. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Company (2021-2026)
Table 28. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sale Price by Company (2021-2026) & (US$/Unit)
Table 29. Key Manufacturers HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Producing Area Distribution and Sales Area
Table 30. Players HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Products Offered
Table 31. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Geographic Region (2021-2026) & (Units)
Table 35. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share Geographic Region (2021-2026)
Table 36. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Country/Region (2021-2026) & (Units)
Table 39. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Country/Region (2021-2026)
Table 40. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Country (2021-2026) & (Units)
Table 43. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Country (2021-2026)
Table 44. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Type (2021-2026) & (Units)
Table 46. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Application (2021-2026) & (Units)
Table 47. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Region (2021-2026) & (Units)
Table 48. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Region (2021-2026)
Table 49. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Type (2021-2026) & (Units)
Table 51. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Application (2021-2026) & (Units)
Table 52. Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Country (2021-2026) & (Units)
Table 53. Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Type (2021-2026) & (Units)
Table 55. Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Application (2021-2026) & (Units)
Table 56. Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Country (2021-2026) & (Units)
Table 57. Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Type (2021-2026) & (Units)
Table 59. Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Application (2021-2026) & (Units)
Table 60. Key Market Drivers & Growth Opportunities of HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits
Table 61. Key Market Challenges & Risks of HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits
Table 62. Key Industry Trends of HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits
Table 63. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Distributors List
Table 66. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Customer List
Table 67. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Forecast by Region (2027-2032) & (Units)
Table 68. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Forecast by Country (2027-2032) & (Units)
Table 70. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Forecast by Region (2027-2032) & (Units)
Table 72. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Forecast by Country (2027-2032) & (Units)
Table 74. Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Forecast by Country (2027-2032) & (Units)
Table 76. Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Forecast by Type (2027-2032) & (Units)
Table 78. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Forecast by Application (2027-2032) & (Units)
Table 80. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. Guangzhou Wondfo Biotech Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 82. Guangzhou Wondfo Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 83. Guangzhou Wondfo Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Guangzhou Wondfo Biotech Co., Ltd. Main Business
Table 85. Guangzhou Wondfo Biotech Co., Ltd. Latest Developments
Table 86. ACON Biotech Hangzhou Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 87. ACON Biotech Hangzhou Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 88. ACON Biotech Hangzhou Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. ACON Biotech Hangzhou Co., Ltd. Main Business
Table 90. ACON Biotech Hangzhou Co., Ltd. Latest Developments
Table 91. Hangzhou AllTest Biotech Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 92. Hangzhou AllTest Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 93. Hangzhou AllTest Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Hangzhou AllTest Biotech Co., Ltd. Main Business
Table 95. Hangzhou AllTest Biotech Co., Ltd. Latest Developments
Table 96. Zhejiang Orient Gene Biotech Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 97. Zhejiang Orient Gene Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 98. Zhejiang Orient Gene Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Zhejiang Orient Gene Biotech Co., Ltd. Main Business
Table 100. Zhejiang Orient Gene Biotech Co., Ltd. Latest Developments
Table 101. InTec PRODUCTS, INC. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 102. InTec PRODUCTS, INC. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 103. InTec PRODUCTS, INC. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. InTec PRODUCTS, INC. Main Business
Table 105. InTec PRODUCTS, INC. Latest Developments
Table 106. Tulip Diagnostics Pvt Ltd Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 107. Tulip Diagnostics Pvt Ltd HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 108. Tulip Diagnostics Pvt Ltd HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Tulip Diagnostics Pvt Ltd Main Business
Table 110. Tulip Diagnostics Pvt Ltd Latest Developments
Table 111. Hangzhou Biotest Biotech Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 112. Hangzhou Biotest Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 113. Hangzhou Biotest Biotech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Hangzhou Biotest Biotech Co., Ltd. Main Business
Table 115. Hangzhou Biotest Biotech Co., Ltd. Latest Developments
Table 116. Assure Tech Hangzhou Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 117. Assure Tech Hangzhou Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 118. Assure Tech Hangzhou Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Assure Tech Hangzhou Co., Ltd. Main Business
Table 120. Assure Tech Hangzhou Co., Ltd. Latest Developments
Table 121. CTK Biotech, Inc. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 122. CTK Biotech, Inc. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 123. CTK Biotech, Inc. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. CTK Biotech, Inc. Main Business
Table 125. CTK Biotech, Inc. Latest Developments
Table 126. Hangzhou Realy Tech Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 127. Hangzhou Realy Tech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 128. Hangzhou Realy Tech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Hangzhou Realy Tech Co., Ltd. Main Business
Table 130. Hangzhou Realy Tech Co., Ltd. Latest Developments
Table 131. Hangzhou Testsea Biotechnology Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 132. Hangzhou Testsea Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 133. Hangzhou Testsea Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Hangzhou Testsea Biotechnology Co., Ltd. Main Business
Table 135. Hangzhou Testsea Biotechnology Co., Ltd. Latest Developments
Table 136. AccuBioTech Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 137. AccuBioTech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 138. AccuBioTech Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. AccuBioTech Co., Ltd. Main Business
Table 140. AccuBioTech Co., Ltd. Latest Developments
Table 141. Fortress Group Holdings Limited Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 142. Fortress Group Holdings Limited HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 143. Fortress Group Holdings Limited HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Fortress Group Holdings Limited Main Business
Table 145. Fortress Group Holdings Limited Latest Developments
Table 146. Zhejiang Wantaifu Biotechnology Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 147. Zhejiang Wantaifu Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 148. Zhejiang Wantaifu Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. Zhejiang Wantaifu Biotechnology Co., Ltd. Main Business
Table 150. Zhejiang Wantaifu Biotechnology Co., Ltd. Latest Developments
Table 151. Ningbo Best-Test Biotechnology Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 152. Ningbo Best-Test Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 153. Ningbo Best-Test Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 154. Ningbo Best-Test Biotechnology Co., Ltd. Main Business
Table 155. Ningbo Best-Test Biotechnology Co., Ltd. Latest Developments
Table 156. Gaobeidian PRISES Biotechnology Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 157. Gaobeidian PRISES Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 158. Gaobeidian PRISES Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 159. Gaobeidian PRISES Biotechnology Co., Ltd. Main Business
Table 160. Gaobeidian PRISES Biotechnology Co., Ltd. Latest Developments
Table 161. Nantong Diagnos Biotechnology Co., Ltd. Basic Information, HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 162. Nantong Diagnos Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Product Portfolios and Specifications
Table 163. Nantong Diagnos Biotechnology Co., Ltd. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 164. Nantong Diagnos Biotechnology Co., Ltd. Main Business
Table 165. Nantong Diagnos Biotechnology Co., Ltd. Latest Developments

LIST OF FIGURES

Figure 1. Picture of HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits
Figure 2. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Growth Rate 2021-2032 (Units)
Figure 7. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Country/Region (2025)
Figure 10. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single-Device Integrated Cassette
Figure 12. Product Picture of Dual-Cassette Panel Holder
Figure 13. Product Picture of Other
Figure 14. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Type in 2026
Figure 15. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Whole-Blood-Compatible Products
Figure 17. Product Picture of Serum-Plasma Products
Figure 18. Product Picture of Other
Figure 19. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Specimen Compatibility in 2026
Figure 20. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Specimen Compatibility (2021-2026)
Figure 21. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Consumed in Preoperative Screening
Figure 22. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Market: Preoperative Screening (2021-2026) & (Units)
Figure 23. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Consumed in Antenatal Screening
Figure 24. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Market: Antenatal Screening (2021-2026) & (Units)
Figure 25. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Consumed in STI Screening
Figure 26. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Market: STI Screening (2021-2026) & (Units)
Figure 27. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Consumed in Transfusion-Transmitted Infection Screening
Figure 28. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Market: Transfusion-Transmitted Infection Screening (2021-2026) & (Units)
Figure 29. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Consumed in Other
Figure 30. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Market: Other (2021-2026) & (Units)
Figure 31. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sale Market Share by Application (2025)
Figure 32. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Application in 2025
Figure 33. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales by Company in 2025 (Units)
Figure 34. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Company in 2025
Figure 35. HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue by Company in 2025 ($ millions)
Figure 36. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Company in 2025
Figure 37. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Geographic Region in 2025
Figure 39. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales 2021-2026 (Units)
Figure 40. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue 2021-2026 ($ millions)
Figure 41. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales 2021-2026 (Units)
Figure 42. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue 2021-2026 ($ millions)
Figure 43. Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales 2021-2026 (Units)
Figure 44. Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales 2021-2026 (Units)
Figure 46. Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue 2021-2026 ($ millions)
Figure 47. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Country in 2025
Figure 48. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Country (2021-2026)
Figure 49. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Type (2021-2026)
Figure 50. Americas HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Application (2021-2026)
Figure 51. United States HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Region in 2025
Figure 56. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Region (2021-2026)
Figure 57. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Type (2021-2026)
Figure 58. APAC HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Application (2021-2026)
Figure 59. China HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 63. India HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Country in 2025
Figure 67. Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share by Country (2021-2026)
Figure 68. Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Type (2021-2026)
Figure 69. Europe HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Application (2021-2026)
Figure 70. Germany HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 71. France HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 72. UK HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share by Application (2021-2026)
Figure 78. Egypt HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits in 2026
Figure 84. Manufacturing Process Analysis of HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits
Figure 85. Industry Chain Structure of HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits
Figure 86. Channels of Distribution
Figure 87. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Forecast by Region (2027-2032)
Figure 88. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global HIV/HBV/HCV/Syphilis Quadruple Rapid Test Kits Revenue Market Share Forecast by Application (2027-2032)